Detailed Narrative
Q3 and 9 Months FY25 Financial Performance
GPT Healthcare reported a 6% year-on-year increase in revenue from operations for Q3 FY25, reaching INR 102 crores. Profit After Tax (PAT) for the quarter also grew by 6% to INR 12 crores. For the nine-month period, PAT stood at INR 37 crores with a 12% margin, while EBITDA margin was 22%, reflecting a 2% increase in EBITDA to INR 69.6 crores. The company's ARPOB for 9 months FY25 was INR 36,700, and the Average Length of Stay (ALOS) reduced to 3.54 days from 3.98 days in the prior year.
New Hospital Expansion and Capacity Targets
The company is steadfast in its goal to become a 1,000-bed hospital chain within the next 2 to 3 years. A new 152-bed ILS Hospital Raipur, involving a INR 55 crore investment and an asset-light rental model, is expected to commence operations in early April. Additionally, an MOU has been signed for a third hospital in Jamshedpur, which will have a capacity of 150 beds with an estimated outlay of INR 65 crores, projected to be operational by October 2026. These expansions are crucial for scaling operations and reaching underserved communities.
Operational Efficiency and Case Mix Improvement
GPT Healthcare is actively working to improve operational metrics, including a focus on reducing the Average Length of Stay (ALOS). For instance, Dum Dum Hospital's ALOS reduced from 5.29 days to 4.57 days year-on-year, and the company aims for a further 0.25-day reduction. This strategy, combined with a shift towards more complex treatments like transplants and robotic surgeries, has led to an increase in ARPOB across hospitals, with ILS Salt Lake seeing a 16.6% rise to INR 39,200 for 9M FY25. While this has led to a slight dip in occupancy, inpatient volumes have increased overall.
Market Strategy and Geographic Focus
The company's expansion into Raipur is driven by the low bed-to-population ratio in Chhattisgarh (11-12 beds per 10,000) and limited national player presence. GPT Healthcare plans to cater to the entire state of Chhattisgarh and Odisha, focusing on cash and insurance patients. In terms of medical tourism, the company continues to focus on Bangladesh, which historically contributed 10% of Agartala's patient volumes, and is also increasing its focus on Bhutan, despite recent impacts from geopolitical disputes in Bangladesh.
Capital Allocation and Debt Management
GPT Healthcare has demonstrated strong debt management, resulting in a 55% reduction in finance costs. The company currently holds approximately INR 45 crores in cash on its balance sheet and is considered net debt-free. Management indicated a willingness to take on judicious debt for future growth initiatives without equity dilution, highlighting sufficient headroom. The company is also actively evaluating acquisition opportunities for ongoing hospitals in cities like Guwahati, Bhubaneswar, and Patna to accelerate bed capacity expansion.
Challenges and Future Outlook
Despite reaffirming its long-term target of 15% CAGR revenue growth and maintaining EBITDA margins between 22% to 23% over the next 2-3 years, FY25 growth has been flat due to unforeseen external factors. These include the RG Kar incident, the Bangladesh dispute, and floods in Tripura, which impacted overall productivity. The Ranchi project is also facing significant delays, leading the company to pursue Jamshedpur as a safeguard. Management expressed confidence in returning to growth parameters soon.